Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Virginie Kergourlay
Observed name:
V. Kergourlay
Institutions:
Orion Corporation (Finland),
Orion Corporation (United Kingdom)
Observed institutions:
Inserm,
Aix-Marseille Université,
Orion Corporation (Finland),
Génétique Médicale & Génomique Fonctionelle,
Centre de Génétique Médicale de Marseille,
Orion Corporation (United Kingdom)
show all 6
ORCID:
0000-0001-5845-4222
Observed ORCID:
0000-0001-5845-4222
OpenAlex ID:
A5031686701
Exon 32 Skipping of Dysferlin Rescues Membrane Repair in Patients’ Cells
2015
·
Florian Barthélémy
, Cédric Blouin
, et al.
·
Journal of Neuromuscular Diseases
·
44
PDF
Identification of Splicing Defects Caused by Mutations in the Dysferlin Gene
2014
·
Virginie Kergourlay
, Ghadi Raï
, et al.
·
Human Mutation
·
30
PDF
Correction of pseudoexon splicing caused by a novel intronic dysferlin mutation
2019
·
Janice A. Dominov
, Özgün Uyan
, et al.
·
Annals of Clinical and Translational Neurology
·
26
PDF
The Dysferlin Transcript Containing the Alternative Exon 40a is Essential for Myocyte Functions
2021
·
Océane Ballouhey
, Sébastien Courrier
, et al.
·
Frontiers in Cell and Developmental Biology
·
19
PDF
Novel Pathogenic Variants in a French Cohort Widen the Mutational Spectrum of GNE Myopathy
2015
·
Mathieu Cerino
, Svetlana Gorokhova
, et al.
·
Journal of Neuromuscular Diseases
·
13
PDF
Establishing a GMP-compliant manufacturing process and phase-appropriate analytics for early development of a FiCAR T-cell product with a novel CAR spacer
2025
·
Annu Luostarinen
, Arja Vuorela
, et al.
·
Scientific Reports
·
9
Comment on: A novel dysferlin‐mutant pseudoexon bypassed with antisense oligonucleotides
2015
·
Virginie Kergourlay
, Gaëlle Blandin
, et al.
·
Annals of Clinical and Translational Neurology
·
2
PDF
T.P.27 Characterization of the modular domains of dysferlin for gene transfer
2012
·
F. Barthélémy
, V. Kergourlay
, et al.
·
Neuromuscular Disorders
·
1
Stabilizing Long CARs for Optimal Anti-Tumor Responses in Hematological Malignancies
2025
·
Jan Koski
, Henrik Paavilainen
, et al.
·
Research Square
PDF
Abstract 47: Stabilization of long CAR T cells is crucial for in vivo antitumor efficacy
2024
·
Henrik Paavilainen
, Jan Koski
, et al.
·
Cancer Research
Mise au point d'outils novateurs pour l'identification de mutations pathogènes : le cas des dysferlinopathies
2014
·
Virginie Kergourlay
·
theses.fr (ABES)
Show more works
View as search
Works count:
11
Citation count:
144
H-index:
6
I10-index:
5
Year
Topic
Type